(480) 923-0802
Join Our Panel
Consulting
Insights
Podcast
DVI
About
Contact Us
Posts Tagged ‘prescription drugs
All Categories
Our Take Newsletter
Downloadable Articles
By the Numbers
September 01, 2021
Our Take: Vaccine update: Pfizer, BioNTech get full FDA nod, Moderna completes its BLA submission
Read More
August 23, 2021
Our Take: J&J, Cerner announce shake-ups in top leadership, Google Health splitting up
Read More
August 16, 2021
Our Take: Honor Technologies acquires Home Instead with goal of scaling up high-quality senior home care
Read More
August 09, 2021
Our Take: COVID-19 appears to be an independent risk factor for heart attack, stroke, large study shows
Read More
August 02, 2021
Our Take: As FDA approves first interchangeable insulin biosimilar, insurers take steps to restrict use of biosimilars
Read More
July 26, 2021
Our Take: Health systems, insurers take a ‘wait and see; stance on Aduhelm
Read More
July 19, 2021
Our Take: Oral arguments in Pfizer lawsuit renew focus on case that could have industry-wide implications
Read More
July 12, 2021
Our Take: As delta becomes dominant strain, U.S. COVID-19 cases increase nearly 11% in one week
Read More
June 28, 2021
Our Take: Blues plans fund new startup to address high drug prices
Read More
June 21, 2021
Our Take: Beaumont Health and Spectrum Health in talks to form a new 22-hospital health system
Read More
June 14, 2021
Our Take: FDA grants accelerated approval to Biogen’s Alzheimer’s drug, creating more controversy
Read More
June 07, 2021
Our Take: HCA Healthcare to partner with Google Cloud on custom analytics tools
Read More
May 24, 2021
Our Take: JPMorgan Chase picks up where Haven left off
Read More
May 17, 2021
Our Take: BD to spin off diabetes business into new publicly traded company
Read More
Posts navigation
Previous
1
…
9
10
11
…
13
Next
Sign up for Our Take
the weekly strategic brief for Health Care Executives
Please leave this field empty
Business Email
*
Check your inbox or spam folder to confirm your subscription.
share
Contact Darwin Research Group and we will get right back to you.
Please leave this field empty.
Consulting
Insights
Podcast
DVI
About
Contact Us